MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$1,710,779K
Marketable debt securities
$1,298,444K
Accounts receivable, net
$883,957K
Prepaid expenses and
other current assets
$242,103K
Inventory
$84,025K
Total current assets
$4,219,308K
Property, plant and
equipment, net
$518,257K
Operating lease
right-of-use assets
$189,299K
Deferred tax assets
$116,960K
Other assets
$63,553K
Restricted investments
$22,170K
Total assets
$5,129,547K
Total liabilities and
stockholders' equity
$5,129,547K
Total liabilities
$4,054,167K
Total stockholders'
equity
$1,075,380K
Accumulated deficit
-$6,496,533K
Accumulated other
comprehensive loss
-$24,894K
Liabilities related to the
sale of future...
$1,469,684K
Total current
liabilities
$1,349,475K
Convertible debt
$1,009,372K
Operating lease
liabilities, net of current...
$218,025K
Other liabilities
$7,611K
Additional paid-in capital
$7,595,473K
Common stock, 0.01 par
value per share,...
$1,334K
Accrued expenses
$946,485K
Liabilities related to the
sale of future...
$227,488K
Accounts payable
$126,628K
Operating lease
liabilities
$45,661K
Deferred revenue
$3,213K
Back
Back
Balance Sheet
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
source: myfinsight.com